Jan Scicinski - Concepedia

Author

Jan Scicinski

Also Known As

J. J. SCICINSKI, J. J. Scicinski, J. SCICINSKI, J. Scicinski, Jan J Scicinski, Jan J. Scicinski, Jan J. Sciciński, Jan Scicinski, Jan J. Scicinski, Scicinski, J.J.

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)Stanford University Stanford Medicine University of Cambridge University of Hertfordshire

About

Jan Scicinski is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, chemistry, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	12	15	422
2	Medicine	12	14	710
3	Biochemistry	8	8	554
4	Natural Sciences	6	6	503
5	Health Sciences	1	1	31

Jan Scicinski

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Dihydropyrancarboxamides Related to Zanamivir: A New Series of Inhibitors of Influenza Virus Sialidases. 1. Discovery, Synthesis, Biological Activity, and Structure−Activity Relationships of 4-Guanidino- and 4-Amino-4<i>H</i>-pyran-6-carboxamides Paul W. Smith, Steven L. Sollis, Peter D. Howes, Journal of Medicinal Chemistry Greater Inhibitory ActivityNew SeriesAntiviral DrugPharmaceutical ChemistryMolecular Pharmacology	1998	339
Dinitroazetidines Are a Novel Class of Anticancer Agents and Hypoxia-Activated Radiation Sensitizers Developed from Highly Energetic Materials Shoucheng Ning, Mark D. Bednarski, Bryan Oronsky, Cancer Research	2012	101
Six Degrees of Separation: The Oxygen Effect in the Development of Radiosensitizers Bryan Oronsky, Susan J. Knox, Jan Scicinski Translational Oncology	2011	89
Rapid one-pot preparation of 2-substituted benzimidazoles from 2-nitroanilines using microwave conditions David S. VanVliet, Paul Gillespie, Jan Scicinski Tetrahedron Letters 2-Substituted BenzimidazolesChemical EngineeringEngineeringOrganic ChemistryChemistry	2005	89
Novel inhibitors of influenza sialidases related to GG167 structure-activity, crystallographic and Molecular dynamics studies with 4H-pyran-2-carboxylic acid 6-carboxamides Paul W. Smith, Steven L. Sollis, Peter D. Howes, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryInfluenza SialidasesMedicineNatural Sciences	1996	55
Light-fluorous safety-catch arylgermanes ? exceptionally robust, photochemically activated precursors for biaryl synthesis by Pd(0) catalysed cross-coupling Alan C. Spivey, Chih‐Chung Tseng, Joseph P. Hannah, Chemical Communications Chemical EngineeringCross-coupling ReactionEngineeringPhotoredox ProcessPhotochemistry	2007	50
Preclinical Evaluation of the Metabolism and Disposition of RRx-001, a Novel Investigative Anticancer Agent Jan Scicinski, Bryan Oronsky, Michael J. Taylor, Drug Metabolism and Disposition	2012	48
Solid-phase reaction monitoring—Chemical derivatization and off-bead analysis Corinne Kay, Olivier Lorthioir, Nick Parr, Biotechnology and Bioengineering EngineeringChemical AnalysisOrganic ChemistryChemistryOff-bead Analysis	2000	45
Novel nitric oxide generating compound glycidyl nitrate enhances the therapeutic efficacy of chemotherapy and radiotherapy Shoucheng Ning, Mark D. Bednarski, Bryan Oronsky, Biochemical and Biophysical Research Communications Compound GlycidylOncologyReactive Nitrogen SpecieMedicineTherapeutic Efficacy	2014	38
Two Case Reports of Resensitization to Previous Chemotherapy with the Novel Hypoxia-Activated Hypomethylating Anticancer Agent RRx-001 in Metastatic Colorectal Cancer Patients T. Reid, Sania Dad, Ron Korn, Case Reports in Oncology PathologyPharmacotherapyCancer BiologyTumor BiologyCancer Cell Biology	2014	36

Page 1